Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2013


Point of Care: Innovations of the Future

23 Oct 2013 - 24 Oct 2013 - London, UK



Bookmark and Share


Join SMi's highly successful 10th annual Point of Care: Innovations of the Future conference promising to be a must see event!

SMi’s highly respected and eagerly anticipated 10th Annual Point of Care: Innovations of the Future conference comes to London for what promises to be a highly thought provoking and thrilling event. Join a plethora of highly respected speakers as they discuss topics ranging from the analysis of how the future of Point of Care testing will look and change over the next decade to the different strategies medical trusts are putting in place to increase the use of Point of Care testing within the patient care setting. Identify potential gaps in the market for new technologies and learn how to successfully implement these in a highly competitive market place.

This year’s Point of Care: Innovations of the Future conference will focus on technologies aimed at treating infectious diseases, with a focus on the rapid identification and ‘on the spot’ diagnosis of infectious diseases such as HIV and TB. This year’s event will take a look at what strategies different healthcare trusts are implementing to increase the usage of Point of Care testing and diagnosis at the site of the patient.

KEY TOPICS:

Identify key industry trends and market opportunities

Discover new technological applications and the latest advances in device technology

Learn how to overcome potential barriers to commercialisation of a new technology

Gain an insight into the future of POC technologies

Understand the benefits of non-invasive patient testing and how new profiling technologies lead to a better personalised treatment approach


EXPERT SPEAKERS INCLUDE:

Till Bachmann, Reader in Personalised Medicine in Infectious Diseases, University of Edinburgh

Trevor Lewis, CEO, Medical Device Consultancy

Phil Lefebvre, Senior Manager, Business Development, Abbott Laboratories

Penny Wilson, Innovation Platform Leader, Technology Strategy

Roger Peck, Technical Officer, PATH

Tony Gibson, Scientific Director, North East Pathology Network Coordinator

David Huckle, Chief Executive, Adams Business Associates

Maurice O’Kane, Consultant Chemical Pathologist /Director for Research and Development, Western Health and Social Care Trust

Mohammad Al-Ubaydli, CEO, Patients Know Best

Kavita Oberoi, Founder and Managing Director, Oberoi Consulting

Gillian Hall, POCT Coordinator, Royal Brompton and Harefield NHS Foundation Trust

Per Simonsson, Professor of Clinical Chemistry, University Hospital MAS

Nigel Sansom, Senior Manager, Celaris Biosystems

Jose Manuel Costa, Associate Professor, University of Oviedo

Brian Winn, Partner, NHS Institute for Innovation and Improvement

John Rippeth, Principle Consultant, PA Consulting

Contact: Darryl Moxon, Phone: +44 20 7827 6066, Email: dmoxon@smi-online.co.uk

For Sponsorship opportunities contact Alia Malick on +44 (0)20 7827 6168 or email amalick@smi-online.co.uk



Further information
Scientific News
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Making Virus Sensors Cheap and Simple
Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).
Heart Defect Prediction Technology Could Lead to Earlier, More Informed Treatment
Experimental method uses genetics-guided biomechanics, patient-specific stem cells.
Biosensor Detects Molecules Linked to Cancer, Alzheimer's and Parkinson's
Novel biosensor has been proven capable of detecting molecules associated with neurodegenerative diseases and some types of cancer.
Big Data Can Save Lives
The sharing of genetic information from millions of cancer patients around the world could be key to revolutionising cancer prevention and care, according to a leading cancer expert from Queen's University Belfast.
Fast, Simple Test for Colitis
A minimally invasive screening for ulcerative colitis using emerging infrared technology could be a rapid and cost-effective method for detecting disease that eliminates the need for biopsies and intrusive testing of the human body.
Scans Reveal Babies of Mothers with Gestational Diabetes Have More Body Fat
Researchers at Imperial College London have found that the babies born to mothers with gestational diabetes have more body fat at two months of age compared to babies born to healthy mothers.
New Device Could Improve Cancer Detection
UBC researchers develop a microfluidic device to capture circulating tumor cells.
Plasma Biomarkers for Breast Cancer Diagnosis
Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
Newborn Screening Test Developed For Rare, Deadly Neurological Disorder
Scientists have developed a new dried blood spot screening test for Niemann-Pick type C, with goal to speed diagnosis and treatment.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!